Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases

被引:39
作者
Wu, Ning-hua [1 ,2 ]
Ye, Yu [1 ]
Wan, Bin-bin [1 ]
Yu, Yuan-dong [3 ]
Liu, Chao [1 ]
Chen, Qing-jie [1 ]
机构
[1] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning 437000, Hubei, Peoples R China
[2] Hubei Univ Sci & Technol, Basic Med Coll, Xianning 437000, Hubei, Peoples R China
[3] Hubei Univ Med, Renmin Hosp, Dept Oncol, Shiyan 442000, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Sigma-1; receptor; MAM; Neurodegenerative; SIGMAR1; Target drugs; ENDOPLASMIC-RETICULUM; NEUROTROPHIC FACTOR; MOUSE MODEL; PAIN HYPERSENSITIVITY; NEUROPATHIC PAIN; BRAIN PLASTICITY; RAT MODEL; ACTIVATION; PATHWAY; DYSFUNCTION;
D O I
10.1007/s12035-021-02524-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The sigma-1 receptor (Sig-1R) is encoded by the SIGMAR1 gene and is a nonopioid transmembrane receptor located in the mitochondrial-associated endoplasmic reticulum membrane (MAM). It helps to locate endoplasmic reticulum calcium channels, regulates calcium homeostasis, and acts as a molecular chaperone to control cell fate and participate in signal transduction. It plays an important role in protecting neurons through a variety of signaling pathways and participates in the regulation of cognition and motor behavior closely related to neurodegenerative diseases. Based on its neuroprotective effects, Sig-1R has now become a breakthrough target for alleviating Alzheimer's disease and other neurodegenerative diseases. This article reviews the most cutting-edge research on the function of Sig-1R under normal or pathologic conditions and target drugs of the sigma-1 receptor in neurodegenerative diseases.
引用
收藏
页码:5649 / 5666
页数:18
相关论文
共 50 条
[31]   Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain [J].
Carmen Ruiz-Cantero, M. ;
Gonzalez-Cano, Rafael ;
Tejada, Miguel A. ;
Santos-Caballero, Miriam ;
Perazzoli, Gloria ;
Nieto, Francisco R. ;
Cobos, Enrique J. .
PHARMACOLOGICAL RESEARCH, 2021, 163
[32]   Sigma-1 Receptor in Motoneuron Disease [J].
Mancuso, Renzo ;
Navarro, Xavier .
SIGMA RECEPTORS: THEIR ROLE IN DISEASE AND AS THERAPEUTIC TARGETS, 2017, 964 :235-254
[33]   Investigational sigma-1 receptor antagonists for the treatment of pain [J].
Vela, Jose Miguel ;
Merlos, Manuel ;
Almansa, Carmen .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) :883-896
[34]   The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's [J].
Prasanth, Mani Iyer ;
Malar, Dicson Sheeja ;
Tencomnao, Tewin ;
Brimson, James Michael .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (05) :401-414
[35]   Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1G93A ALS Mice [J].
Gaja-Capdevila, Nuria ;
Hernandez, Neus ;
Navarro, Xavier ;
Herrando-Grabulosa, Mireia .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[36]   Intrathecal interleukin-1β decreases sigma-1 receptor expression in spinal astrocytes in a murine model of neuropathic pain [J].
Choi, Sheu-Ran ;
Han, Ho Jae ;
Beitz, Alvin J. ;
Lee, Jang-Hern .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 144
[37]   An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies [J].
Martin, Parthena ;
Reeder, Thadd ;
Sourbron, Jo ;
de Witte, Peter A. M. ;
Gammaitoni, Arnold R. ;
Galer, Bradley S. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
[38]   The sigma-1 receptor: a regulator of cancer cell electrical plasticity? [J].
Crottes, David ;
Guizouarn, Helene ;
Martin, Patrick ;
Borgese, Franck ;
Soriani, Olivier .
FRONTIERS IN PHYSIOLOGY, 2013, 4
[39]   Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS) [J].
Mavlyutov, Timur A. ;
Guo, Lian-Wang ;
Epstein, Miles L. ;
Ruoho, Arnold E. .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) :10-16
[40]   Effects of Sigma-1 Receptor Ligands on Peripheral Nerve Regeneration [J].
Cottilli, Patrick ;
Gaja-Capdevila, Nuria ;
Navarro, Xavier .
CELLS, 2022, 11 (07)